Cargando…

Risk and outcomes of breakthrough COVID‐19 infections in vaccinated immunocompromised patients: A meta‐analysis

Detalles Bibliográficos
Autores principales:	Deng, Guangtong, Zhou, Qian, Meng, Yu, Sun, Huiyan, Du, Songtao, Liu, Yihuang, Zeng, Furong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256991/ https://www.ncbi.nlm.nih.gov/pubmed/37303815 http://dx.doi.org/10.1002/mco2.307

Ejemplares similares

Serological response following COVID-19 vaccines in patients living with HIV: a dose–response meta-analysis
por: Zhou, Qian, et al.
Publicado: (2023)

Clinical characteristics, outcomes, and risk factors of SARS-CoV-2 breakthrough infections among 572 fully vaccinated (BBIBP-CorV) hospitalized patients
por: Liu, Yihuang, et al.
Publicado: (2023)

Correlation between CD4 T-Cell Counts and Seroconversion among COVID-19 Vaccinated Patients with HIV: A Meta-Analysis
por: Zhou, Qian, et al.
Publicado: (2023)

Pretreatment neutrophil-to-lymphocyte ratio predicts the benefit of gastric cancer patients with systemic therapy
por: Du, Songtao, et al.
Publicado: (2021)

Tumor neutrophils ferroptosis: a targetable immunosuppressive mechanism for cancer immunotherapy
por: Du, Songtao, et al.
Publicado: (2023)

The risk of developing second primary malignancies among colorectal cancer patients
por: Du, Songtao, et al.
Publicado: (2022)

Clinical Significance of Plasma D-Dimer in COVID-19 Mortality
por: Li, Yayun, et al.
Publicado: (2021)

Convalescent plasma for patients with COVID-19
por: Zeng, Furong, et al.
Publicado: (2020)

Azvudine versus Paxlovid for oral treatment of COVID-19 in Chinese patients with pre-existing comorbidities
por: Dian, Yating, et al.
Publicado: (2023)

VACCINATED WITH A TWIST: BREAKTHROUGH COVID-19 IN AN IMMUNOCOMPROMISED PATIENT
por: DAOUD, DANA, et al.
Publicado: (2021)

Prognostic and therapeutic significance of a novel ferroptosis related signature in colorectal cancer patients
por: Du, Songtao, et al.
Publicado: (2022)

Clinical determinants for fatality of 44,672 patients with COVID-19
por: Deng, Guangtong, et al.
Publicado: (2020)

The Prognostic Significance of Baseline Neutrophil-to-Lymphocyte Ratio in Melanoma Patients Receiving Immunotherapy
por: Li, Yayun, et al.
Publicado: (2022)

Nomogram based on autophagy related genes for predicting the survival in melanoma
por: Deng, Guangtong, et al.
Publicado: (2021)

Elevated troponin levels predict the reduced efficacy of Paxlovid in COVID-19 patients
por: Zhao, Deze, et al.
Publicado: (2023)

COVID-19 Breakthrough Infections in Vaccinated Patients With CLL in Israel
por: Yekutiel, Naama, et al.
Publicado: (2023)

Targeting Ferroptosis by Ubiquitin System Enzymes: A Potential Therapeutic Strategy in Cancer
por: Meng, Yu, et al.
Publicado: (2022)

BET inhibitors synergize with sunitinib in melanoma through GDF15 suppression
por: Zeng, Furong, et al.
Publicado: (2023)

Predictors of death in COVID-19 vaccine breakthrough infections in Brazil
por: Estofolete, Cassia Fernanda, et al.
Publicado: (2022)

Characteristics of pregnant patients with COVID-19 and liver injury
por: Deng, Guangtong, et al.
Publicado: (2020)

Severe breakthrough COVID‐19 infections in vaccinated patients with schizophrenia in Israel
por: Tzur Bitan1,2, Dana, et al.
Publicado: (2022)

Sinopharm Vaccine, SARS-CoV-2 Breakthrough Infections and Hemoglobinopathies
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Investigation of vaccine breakthrough infections by vaccination scheme during the Delta variant wave in France
por: Bal, Antonin, et al.
Publicado: (2022)

COVID-19 vaccination in immunocompromised patients
por: Sonani, Bhavin, et al.
Publicado: (2021)

EEF2K silencing inhibits tumour progression through repressing SPP1 and synergises with BET inhibitors in melanoma
por: Deng, Guangtong, et al.
Publicado: (2022)

Breakthrough monkeypox infection among individuals previously immunized with smallpox or monkeypox vaccination
por: Raccagni, Angelo Roberto, et al.
Publicado: (2022)

Commentary on: Nomograms based on inflammatory biomarkers for predicting tumor grade and microvascular invasion in stage I/II hepatocellular carcinoma
por: Xiao, Liang, et al.
Publicado: (2019)

The anti-ferroptotic role of FSP1: current molecular mechanism and therapeutic approach
por: Zeng, Furong, et al.
Publicado: (2022)

Rate and risk factors for breakthrough SARS-CoV-2 infection after vaccination
por: Butt, Adeel A., et al.
Publicado: (2021)

Monkeypox breakthrough infections and side-effects: Clarion call for nex-gen novel vaccine
por: Mohapatra, Ranjan K., et al.
Publicado: (2023)

SARS-CoV-2 breakthrough infections in vaccinated kidney transplant recipients: an issue of concern
por: Wijtvliet, Veerle, et al.
Publicado: (2021)

SARS-CoV-2 vaccine breakthrough infection following a previous infection in a healthcare worker
por: Gupta, Aayush, et al.
Publicado: (2022)

Breakthrough Bloodstream Infections Caused by Echinocandin-Resistant Candida tropicalis: An Emerging Threat to Immunocompromised Patients with Hematological Malignancies
por: Sfeir, Maroun M., et al.
Publicado: (2020)

SARS-CoV-2 breakthrough infections in vaccinated individuals requiring ventilatory support for severe acute respiratory failure
por: Finazzi, Stefano, et al.
Publicado: (2023)

Omicron breakthrough infections in vaccinated or previously infected hamsters
por: Zhou, Jie, et al.
Publicado: (2023)

Persistent Human Metapneumovirus Infection in Immunocompromised Child
por: Abed, Yacine, et al.
Publicado: (2008)

Atypical Chikungunya Virus Infections in Immunocompromised Patients
por: Kee, Adrian C.L., et al.
Publicado: (2010)

Regular and booster vaccination with inactivated vaccines enhance the neutralizing activity against Omicron variant both in the breakthrough infections and vaccinees
por: YangYang, et al.
Publicado: (2022)

Association of inflammatory markers with the severity of COVID-19: A meta-analysis
por: Zeng, Furong, et al.
Publicado: (2020)

Prevalence and Clinical Outcome of Omicron Breakthrough Infection in Patients With Hematologic Disease: A Prospective Observational Cohort Study
por: Narita, Kentaro, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a1tflg3dmm9282m8vffj0guvqf